ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q2SCImago #11,578Hybrid

Journal of Clinical and Experimental Hematopathology

Identifier (ISSN):1346-4280(Print)/1880-9952(Online)
•
Publisher:The Japanese Society for Lymphoreticular Tissue Research
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
1.4– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Journal of Clinical and Experimental Hematopathology

WoS Q4
01121.520230.920241.420251.42026
Annual Impact Factor Metric
Current (2026):1.4
Scopus SJR & RankScopus Q2
0.514
#11,578

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
37

37 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate11.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
29articles/year
99.2% Gold OA•74.42% Original Research

Aims & Scope

Journal of Clinical and Experimental Hematopathology (ISSN: 1346-4280) is a peer-reviewed international scholarly journal in the field of HEMATOLOGY, published by The Japanese Society for Lymphoreticular Tissue Research in Japan. The periodical holds a Journal Impact Factor (JIF) of 1.40, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.514 (Q2), an H-index of 37.

Topics Covered (Recognized by AI)
Medicine96.6%Biology95.6%Internal medicine95.2%Immunology92.1%Pathology86.9%Genetics85.3%Lymphoma60.6%Chemistry51.3%Surgery50.9%Biochemistry45.7%Antibody34.7%Cancer research34.1%Chemotherapy29.9%Cell biology26.9%Gene24.8%Disease24.8%Gastroenterology22.6%Immune system20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

HEMATOLOGY

Q4
Rank78/103
IndexESCI
JCIESCI2026

HEMATOLOGY

Q4
Rank82/103
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.4
Articles / Year21
Total Citations5
2025
IF1.4
Articles / Year51
Total Citations20
2024
IF0.9
Articles / Year46
Total Citations108
2023
IF1.5
Articles / Year40
Total Citations141
2022
IF—
Articles / Year35
Total Citations255

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,578Scopus Q2SCImago Profile
Scopus Coverage:2006-2016, 2019-2025
Scopus Broad Areas:MedicineNursing
Scopus Citation Rank (SJR)Q2
0.514

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.31

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,964 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations177
3-Year Documents127
Citable Documents119

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate33.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PathophysiologyQ2
HematologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 11.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Clinical and Experimental Hematopathology (ISSN: 1346-4280) is a peer-reviewed international scholarly journal in the field of HEMATOLOGY, published by The Japanese Society for Lymphoreticular Tissue Research in Japan. The periodical holds a Journal Impact Factor (JIF) of 1.40, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.514 (Q2), an H-index of 37.

The journal enforces rigorous peer evaluation with an annual output of approximately 29 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,964 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
The Japanese Society for Lymphoreticular Tissue Research
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: faee16b4-c98c-4137-85cc-355b6365c62f
Database Updated: 2026-10-01